
Commentary|Videos|April 23, 2026
COA 2026: Turning Policy Into Practice: Why Advocacy Matters in Community Oncology
Advertisement
In this Community Oncology Alliance (COA) pre-conference interview with Pharmacy Times, Nick Ferreyros discusses the importance of making health policy relevant by connecting it directly to patient care and clinical practice. He highlights new data from collaboration with Flatiron Health showing strong outcomes in community oncology, helping to challenge outdated perceptions. Ferreyros also warns of key policy threats, including the Inflation Reduction Act, and ongoing challenges with pharmacy benefit managers that may impact care delivery. He emphasizes that provider advocacy is essential to driving change and protecting access to care. You can view more coverage from COA
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
5





































































































































